SBIJI Innovation
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002...
top of page
Search
SBIJI Innovation
Jul 6, 20211 min
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
MONMOUTH JUNCTION, N.J. and AIRPORT CITY, Israel, July 06, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (“Advaxis”) (NASDAQ: ADXS) and Biosight...
58 views0 comments
SBIJI Innovation
Jun 13, 20211 min
LogicBio Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial
LogicBio Therapeutics Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial for the Treatment of Pediatric...
35 views0 comments
SBIJI Innovation
Apr 28, 20211 min
Chemomab Announces Enrollment of First Patient in Phase 2a Study of CM-101 in NASH
The study aims to further validate the anti-fibrotic and anti-inflammatory activity of CM-101 while providing safety and PK data to...
26 views0 comments
SBIJI Innovation
Apr 28, 20211 min
LogicBio Therapeutics Announces Research Collaboration with Daiichi Sankyo
- Under the terms of the research collaboration and exclusive option agreement, the companies will initiate a gene editing research...
20 views0 comments
bottom of page